| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |